Idiopathic Pulmonary Fibrosis: Diagnosis, Treatment, and Supportive Care

e-Learning

This course is available for free as part of the CHEST e-Learning Library.
Access this and other e-learning activities by clicking the button below.

View e-Learning Library >

The idiopathic pulmonary fibrosis program discusses the disease state and progresses through the steps to properly diagnose and apply treatment options, and how to conduct continuous supportive care discussions between clinicians, patients, and family members.

Recognition Statement

This educational activity was developed in partnership with and funded by Boehringer Ingelheim Pharmaceuticals, Inc.

Learning Objectives

Identify and determine the proper diagnosis of IPF patients.
Implement a variety of current treatment and therapy options for IPF patients.
Recommend and administer a palliative and end of life care program for patients, caregivers, and family members.

Item Number: 92552

Faculty

Gregory P. Cosgrove, MD, FCCP
Associate Professor of Medicine
Division of Pulmonary, Critical Care and Sleep Medicine
National Jewish Health
Denver, CO
Disclosure: Nothing to disclose.

Joao A. de Andrade, MD, FCCP
Professor of Medicine
Chief Medical Officer, Vanderbilt Lung Institute
Associate Director, Division of Allergy, Pulmonary and Critical Care Medicine
Vanderbilt University Medical Center
Nashville, TN
Disclosure: Research grant, consultant, and speaker: Genentech, Boehringer Ingelheim; Editorial Board Member: Annals of the ATS; Committee member: ATS, Pulmonary Fibrosis Foundation Clinical Care Network

Lisa H. Lancaster, MD, FCCP
Associate Professor of Medicine
Allergy, Pulmonary, and Critical Care Medicine
Department of Medicine
Medical Director, Interstitial Lung Disease
Vanderbilt University Medical Center
Nashville, TN
Disclosure: Nothing to disclose.

Wendi Mason, RN, MSN, ACNP-BC
Assistant in Medicine
Program Director, Interstitial Lung Disease Program
Allergy, Pulmonary, and Critical Care Medicine
Department of Medicine
Vanderbilt University Medical Center
Nashville, TN
Disclosure: Consultant: Boehringer Ingelheim, Genentech; Board of Directors Member: Pulmonary Fibrosis Foundation

Katherine Rosen, RN, MSN, ANP-BC
Nurse Practitioner
Interstitial Lung Disease Clinic
Division of Pulmonary, Critical Care and Sleep Medicine
National Jewish Health
Denver, CO
Disclosure: Nothing to disclose.

Nneka Sederstrom, PhD, MA, FCCP
Director of Clinical Ethics
Children’s Minnesota
Minneapolis, MN
Disclosure: Board Member/Committee Chair/Committee Member: American Society of Bioethics and Humanities, Society of Critical Care Medicine Ethics Committee, CHEST Palliative Care and End of Life Network, American Society of Clinical Oncology Ethics, and Society of Critical Care Medicine Patient and Family Commit

Keith Swetz, MD, MA
Associate Professor of Medicine
University of Alabama School of Medicine
Section Chief of Palliative Care
Birmingham VA Medical Center
Medical Director
UAB Medicine Supportive Care and Survivorship Clinic
Birmingham, AL
Disclosure: Nothing to disclose.